CD14 and rheumatoid arthritis: Analysis of circulating CD14+ MOs and CD14−CD16−CD11c+ precursors in our RA cohort showed that while the abundance of CD14+ MOs was not affected in RA, CD14−CD16−CD11c+ precursors were significantly reduced (figure 5A).